Better glycemic control in the hospital: Beneficial and feasible

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 2, 2007, Pages 111-120

  Clement, Stephen ^a,b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

DIABETES MELLITUS; DRUG EFFECT; DRUG MONITORING; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; PATIENT CARE; PRACTICE GUIDELINE; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS; DRUG MONITORING; GLYCEMIC INDEX; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; INSULIN; PATIENT CARE TEAM; PRACTICE GUIDELINES;

EID: 34047098353     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.2.111     Document Type: Article

References (14)

1. Umplerrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabohi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982.
2. Thomas MC, Mathew TH, Russ GR, Rao MM, Moran J. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001; 72:1321-1324.
3. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al. Early post-operative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998; 22:77-81.
4. Fumary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-362.
5. Fumary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-10021.
6. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patient. N Engl J Med 2001; 345:1359-1367.
7. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
8. Leahy JL, Bonner-Weir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 1992; 15:442-455.
9. Shechter M, Bairey Merz CN, Paul-Labrador MJ, Shah PK, Kaul S. Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patients with coronary artery disease. Cardiology 1999; 92:151-155.
10. Clement S, Braithwaite SS, Magee MF, et al; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals (errata in Diabetes Care 2004; 27:856 and Diabetes Care 2004; 27:1255). Diabetes Care 2004; 27:553-591.
11. Garber AJ, Moghissi ES, Bransome ED Jr, et al; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocrinol Pract 2004; 10:77-82.
12. Quealle WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997; 157:545-552.
13. Husband DJ, Pernet A. Gill GV, Hanning I, Alberti KG. The metabolic response to insulin deprivation in idiopathic brittle diabetes. Diabetes Res 1986; 3:193-198.
14. Clement S, Still JG, Kosutic G, McAllister RG. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther 2002; 4:459-466.